Pharmacokinetics and changes in lipid mediator profiling after consumption of specialized pro-resolving lipid-mediator-enriched marine oil in healthy subjects

P Irún, P Carrera-Lasfuentes… - International Journal of …, 2023 - mdpi.com
Omega-3 polyunsaturated fatty acids (PUFAs) play a vital role in human health, well-being,
and the management of inflammatory diseases. Insufficient intake of omega-3 is linked to …

Effects of low-dose aspirin in bipolar disorder: study protocol for a randomised controlled trial (the A-Bipolar RCT)

CF Bruun, J Zarp, JL Forman, K Coello… - BMJ open, 2024 - bmjopen.bmj.com
Introduction Accumulating data support the association between increased inflammation
and bipolar disorder (BD), and preliminary data suggest that augmentation with low-dose …

Metabolic syndrome promotes resistance to aspirin in mitigating bone loss in murine periodontal disease

LS de Rossi, RP Nakama, LF Dos Santos… - Life Sciences, 2024 - Elsevier
Aims This study aimed to investigate the protective effects of aspirin (ASA) on alveolar bone
loss in a mouse model with metabolic syndrome (MetS) and concurrent periodontal disease …

A meta-analysis of the efficacy and safety of aspirin in the treatment of elderly patients with sepsis.

J Zhang, J Wu - Pakistan Journal of Pharmaceutical …, 2024 - search.ebscohost.com
This study aimed to use meta-analytic techniques to evaluate aspirin's safety and
effectiveness in treating elderly patients with sepsis. We searched PubMed, Embase, The …

Synthesis of a new alkyne analog of BML-111

YR Aliev - 2024 - duo.uio.no
Many chronic illnesses are linked to chronic inflammation in the body. The body naturally
produces molecules called specialized pro-resolving mediators (SPMs) to resolve …